research TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model 16 citations , December 2016 in “Neuropharmacology” Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.
research Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy 12 citations , December 2018 in “Clinical Ophthalmology” Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.
research The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension 22 citations , March 2019 in “European Journal of Ophthalmology” Preservative-free latanoprost effectively lowers eye pressure with fewer side effects.
research Hypertrichosis of the eyelashes caused by bimatoprost 65 citations , November 2004 in “Journal of the American Academy of Dermatology” Bimatoprost can cause excessive eyelash growth.
research Prostanoid receptors in anagen human hair follicles 39 citations , November 2007 in “Experimental dermatology” Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.